Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Survey on Consumers' Emotional and Cognitive Reactions to Food Recalls, 20990-20992 [2011-8936]

Download as PDF 20990 Federal Register / Vol. 76, No. 72 / Thursday, April 14, 2011 / Notices Desk Officer for the Administration for Children and Families. DEPARTMENT OF HEALTH AND HUMAN SERVICES Robert Sargis, Reports Clearance Officer. Administration for Children and Families Description: A voluntary program which provides State Child Support Enforcement agencies, upon their request, access to the earned and unearned income information reported to IRS by employers and financial institutions. The IRS 1099 information is used to locate noncustodial parents and to verify income and employment. Respondents: [FR Doc. 2011–9079 Filed 4–13–11; 8:45 am] Submission for OMB review; comment request BILLING CODE 4184–01–P Title: IRS Project 1099. OMB No.: 0970–0183. ANNUAL BURDEN ESTIMATES Number of responses per respondent Number of respondents Instrument Average burden hours per response Total burden hours 1099 Record Specifications ............................................................................. IRS Safeguarding Certification Letter .............................................................. 54 54 12 1 1.96 0.48 1,270.08 25.92 Estimated Total Annual Burden Hours: .................................................... ........................ ........................ ........................ 1,296 Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202–395–7285, E-mail: OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration for Children and Families. Robert Sargis, Reports Clearance Officer. [FR Doc. 2011–9054 Filed 4–13–11; 8:45 am] mstockstill on DSKH9S0YB1PROD with NOTICES BILLING CODE 4184–01–P VerDate Mar<15>2010 18:34 Apr 13, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0267] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Survey on Consumers’ Emotional and Cognitive Reactions to Food Recalls AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by May 16, 2011. SUMMARY: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–new and ‘‘Survey on Consumers’ Emotional and Cognitive Reactions to Food Recalls.’’ Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– ADDRESSES: PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 400B, Rockville, MD 20850, 301–796– 3793. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Survey on Consumers’ Emotional and Cognitive Reactions to Food Recalls— 21 U.S.C. 393(d)(2)(C) (OMB Control Number 0910–NEW) I. Background The proposed ‘‘Survey on Consumers’ Emotional and Cognitive Reactions to Food Recalls’’ will be conducted under a cooperative agreement between the Joint Institute for Food Safety and Applied Nutrition (JIFSAN) and the Center for Risk Communication Research at the University of Maryland. JIFSAN was established in 1996 and is a public and private partnership between FDA and the University of Maryland. The Center for Risk Communication Research will design and administer the study. The proposed study will assess consumers’ emotional and cognitive recollection of certain food recalls and gauge how these recollections affect their current perceptions about food recalls and their inclination to adhere to future recommended food recall behaviors. Existing data show that many consumers do not take appropriate protective actions during a foodborne illness outbreak or food recall (Refs. 1 and 2). For example, 41 percent of U.S. consumers say they have never looked for any recalled product in their home (Ref. 2). Conversely, some consumers overreact to the announcement of a foodborne illness outbreak or food recall. In response to the 2006 fresh, bagged spinach recall which followed a E:\FR\FM\14APN1.SGM 14APN1 20991 Federal Register / Vol. 76, No. 72 / Thursday, April 14, 2011 / Notices multistate outbreak of Escherichia coli O157: H7 infections (Ref. 3), 18 percent of consumers said they stopped buying other bagged, fresh produce because of the spinach recall (Ref. 1). Research shows that emotion plays a large role in decisionmaking, and that individuals may not be conscious of its effects on their behavior (Ref. 4). For example, when people are angry they are likely to place blame, take action, and want justice to be served (Ref. 5). If a particular food recall engenders widespread anger and the anger is coupled with behavior that is less than desirable from a food safety or nutritional standpoint, it is possible that anger will be the lens through which future food recall situations are viewed, thus resulting in similar undesirable behaviors. Findings from this study will help FDA understand the emotional response to food recalls. This will help FDA to design more effective consumer food recall messages during and after a recall. FDA conducts research and educational and public information programs relating to food safety under its broad statutory authority, set forth in section 903(b)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 393(b)(2)), to protect the public health by ensuring that foods are ‘‘safe, wholesome, sanitary, and properly labeled,’’ and in section 903(d)(2)(C), to conduct research relating to foods, drugs, cosmetics, and devices in carrying out the FD&C Act. FDA plans to survey U.S. consumers using a web-based panel of U.S. households to collect information on consumers’ cognitive and emotional reaction to food recalls. The survey will query consumers on their recollection of food recalls within the past 5 years; attitude toward recalled foods; knowledge about particular food recalls; behavior during the food recall; and assessment and appraisals of susceptibility, severity, satisfaction, and self-efficacy. The data will be collected using an online survey. A pool of 10,000 consumers from a Web-based consumer panel will be screened for eligibility based on age (18+ years) and familiarity with recent food recalls. One thousand of eligible consumers will be randomly selected to participate in the survey. The results of the survey will not be used to generate population estimates. The estimated total hour burden of the collection of information is 354 hours (table 1 of this document). To help design and refine the questionnaire, the Center for Risk Communication Research will conduct cognitive interviews by screening 25 adult consumers in order to obtain 8 respondents for the cognitive interviews. Each screening is expected to take 5 minutes (0.083 hours) and each cognitive interview is expected to take 1 hour. The total for cognitive interview activities is 10 hours (2 hours + 8 hours). Subsequently, we will conduct pretests of the study questionnaire before it is administered. We expect that 100 invitations, each taking 2 minutes (0.033 hours), will need to be sent to adult members of the online consumer panel to have 40 of them complete a 10 minute (0.167 hours) pretest. The total for the pretest activities is 10 hours (3 hours + 7 hours). We estimate sending 10,000 survey screeners, each taking 1 minute (0.017 hours), to adult members of the online consumer panel to have 1,000 of them complete a 10 minute (0.167 hours) survey. The total for the survey activities is 337 hours (170 hours + 167 hours). The burden estimate for this study published in the Federal Register of June 18, 2010 (75 FR 34745), has increased from 234 hours to 357 hours. The increase in burden hours represents the addition of cognitive interviews to the study design and correction of a math error. In the Federal Register of June 18, 2010 (75 FR 34745), FDA published a 60-day notice requesting public comment on the proposed collection of information. FDA received two letters containing multiple comments in response to the notice. One letter contained comments outside the scope of the four collection of information topics on which the notice solicits comments and, thus, will not be addressed here. (Comment) One comment suggested that the survey should include consumers whose pets were sickened or had died because of mycotoxins in pet food that resulted in the 2004 pet food recall. (Response) FDA agrees that consumers who were affected by the 2004 pet food recall should be included as survey respondents. These consumers will be included if they are members of the online consumer panel from which the survey sample will be drawn and they are randomly selected from the panel. FDA does not believe that the affected population should be targetsampled because the study focuses on human food recalls rather than pet food recalls. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents Portion of study Annual frequency per response Total annual responses Hours per response Total hours Cognitive interview screener ................................................................ Cognitive interview ............................................................................... Pretest screener ................................................................................... Pretest .................................................................................................. Screener ............................................................................................... Survey .................................................................................................. 25 8 100 40 10,000 1,000 1 1 1 1 1 1 25 8 100 40 10,000 1,000 5/60 1/60 2/60 10/60 1/60 10/60 2 8 3 7 170 167 Total .......................................................................................... ........................ ........................ ........................ .................... 357 mstockstill on DSKH9S0YB1PROD with NOTICES 1 There are no capital costs or operating and maintenance costs associated with this collection of information. II. References The following references have been placed on display in the Division of Dockets Management (see ADDRESSES) and may be seen by interested persons VerDate Mar<15>2010 18:34 Apr 13, 2011 Jkt 223001 between 9 a.m. and 4 p.m., Monday through Friday. 1. Cuite, C., Condry, S., Nucci, M., and Hallman, W., ‘‘Public Response to the Contaminated Spinach Recall of 2006,’’ Publication number RR–0107– 013. New Brunswick, New Jersey: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Rutgers, the State University of New Jersey, Food Policy Institute, 2007. 2. Hallman, W., Cuite, C., and Hooker, N., ‘‘Consumer Responses to Food Recalls: 2009 National Survey Report,’’ Publication number RR–0109–018. New Brunswick, New Jersey: Rutgers, the E:\FR\FM\14APN1.SGM 14APN1 20992 Federal Register / Vol. 76, No. 72 / Thursday, April 14, 2011 / Notices State University of New Jersey, Food Policy Institute, 2009. 3. Acheson, D., ‘‘Outbreak of Escherichia coli 0157 Infections Associated with Fresh Spinach—United States, August–September 2006,’’ 2007. Available at https://first.fda.gov/cafdas/ documents/Acheson_Spinach_Outbreak _2006_FDA_pres.ppt. 4. Han, S., Lerner, J.S., and Keltner, D., ‘‘Feelings and Consumer Decision Making: The Appraisal-Tendency Framework,’’ Journal of Consumer Psychology, 17(3), 158–168, 2007. 5. Lazurus, R.S., Emotion and Adaptation. New York: Oxford University Press, 1991. Dated: April 8, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. for the recently identified impurity 1[(4-methylphenyl)azo]-2-naphthalenol and by removing Appendix A in 21 CFR part 74, which pertains to the ‘‘Ethersoluble matter’’ specification. The Agency has determined under 21 CFR 25.30(i) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required. Dated: April 4, 2011. Mitchell A. Cheeseman, Acting Director, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition. [FR Doc. 2011–8575 Filed 4–13–11; 8:45 am] BILLING CODE 4160–01–P [FR Doc. 2011–8936 Filed 4–13–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration [Docket No. FDA–2011–D–0189] [Docket No. FDA–2011–C–0050] Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Low Level Laser System for Aesthetic Use; Availability Sun Chemical Corp.; Filing of Color Additive Petition AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that Sun Chemical Corp. has filed a petition proposing that the color additive regulations for D&C Red No. 6 and D&C Red No. 7 be amended by replacing the current specification for ‘‘Ether-soluble matter’’ with a maximum limit of 0.015 percent for the recently identified impurity 1-[(4methylphenyl)azo]-2-naphthalenol. FOR FURTHER INFORMATION CONTACT: Teresa A. Croce, Center for Food Safety and Applied Nutrition (HFS–265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740– 3835, 301–436–1281. SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic Act (section 721(d)(1) (21 U.S.C. 379e(d)(1))), notice is given that a color additive petition (CAP 1C0290) has been filed by Sun Chemical Corp., 5020 Spring Grove Ave., Cincinnati, OH 45232. The petition proposes to amend the color additive regulations for D&C Red No. 6 (21 CFR 74.1306 and 74.2306) and D&C Red No. 7 (21 CFR 74.1307 and 74.2307) by replacing the current specification for ‘‘Ether-soluble matter’’ with a maximum limit of 0.015 percent mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:34 Apr 13, 2011 Jkt 223001 International, and Consumer Assistance, Office of Communication, Education and Radiation Programs, Center for Devices and Radiological Health (CDRH), Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 4613, Silver Spring, MD 20993– 0002. Send one self-addressed adhesive label to assist that office in processing your request, or fax your request to 301– 847–8149. See the SUPPLEMENTARY INFORMATION section for information on electronic access to the guidance. Submit electronic comments on the guidance to https://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Richard Felten, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1436, Silver Spring, MD 20993–0002, 301–796–6392. SUPPLEMENTARY INFORMATION: I. Background Elsewhere in this issue of the Federal Register, FDA is publishing a final rule classifying low level laser systems for aesthetic use into class II (special controls) under section 513(f)(2) of the AGENCY: Food and Drug Administration, Federal Food, Drug, and Cosmetic Act HHS. (the FD&C Act) (21 U.S.C. 360c(f)(2)). This guidance document will serve as ACTION: Notice. the special control for low level laser SUMMARY: The Food and Drug systems for aesthetic use. Section Administration (FDA) is announcing the 513(f)(2) of the FD&C Act provides that availability of the guidance entitled any person who submits a premarket ‘‘Class II Special Controls Guidance notification under section 510(k) of the Document: Low Level Laser System for FD&C Act (21 U.S.C. 360(k)) for a device Aesthetic Use.’’ This guidance document that has not previously been classified describes a means by which low level may, within 30 days after receiving an laser systems for aesthetic use may order classifying the device in class III comply with the requirement of special under section 513(f)(1) of the FD&C Act, controls for class II devices. Elsewhere request FDA to classify the device under in this issue of the Federal Register, the criteria set forth in section 513(a)(1) FDA is publishing a final rule to classify of the FD&C Act. FDA shall, within 60 low level laser systems for aesthetic use days of receiving such a request, classify into class II (special controls). This the device by written order. This guidance document is being classification shall be the initial immediately implemented as the special classification of the device. Within 30 control for low level laser systems for days after the issuance of an order aesthetic use, but it remains subject to classifying the device, FDA must comment in accordance with the publish a notice in the Federal Register Agency’s good guidance practices. announcing such classification. Because DATES: Submit either electronic or of the timeframes established by section written comments on the guidance at 513(f)(2) of the FD&C Act, FDA has any time. General comments on Agency determined, under § 10.115(g)(2) (21 guidances are welcome at any time. CFR 10.115(g)(2)), that it is not feasible to allow for public participation before ADDRESSES: Submit written requests for issuing this guidance as a final guidance single copies of the guidance document document. Thus, FDA is issuing this entitled ‘‘Class II Special Controls guidance document as a level 1 Guidance Document: Low Level Laser guidance document that is immediately System for Aesthetic Use’’ to the in effect. FDA will consider any Division of Small Manufacturers, PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 76, Number 72 (Thursday, April 14, 2011)]
[Notices]
[Pages 20990-20992]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8936]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0267]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Survey on Consumers'
Emotional and Cognitive Reactions to Food Recalls

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by May 16,
2011.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-new and
``Survey on Consumers' Emotional and Cognitive Reactions to Food
Recalls.'' Also include the FDA docket number found in brackets in the
heading of this document.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B,
Rockville, MD 20850, 301-796-3793.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Survey on Consumers' Emotional and Cognitive Reactions to Food
Recalls--21 U.S.C. 393(d)(2)(C) (OMB Control Number 0910-NEW)

I. Background

The proposed ``Survey on Consumers' Emotional and Cognitive
Reactions to Food Recalls'' will be conducted under a cooperative
agreement between the Joint Institute for Food Safety and Applied
Nutrition (JIFSAN) and the Center for Risk Communication Research at
the University of Maryland. JIFSAN was established in 1996 and is a
public and private partnership between FDA and the University of
Maryland. The Center for Risk Communication Research will design and
administer the study.
The proposed study will assess consumers' emotional and cognitive
recollection of certain food recalls and gauge how these recollections
affect their current perceptions about food recalls and their
inclination to adhere to future recommended food recall behaviors.
Existing data show that many consumers do not take appropriate
protective actions during a foodborne illness outbreak or food recall
(Refs. 1 and 2). For example, 41 percent of U.S. consumers say they
have never looked for any recalled product in their home (Ref. 2).
Conversely, some consumers overreact to the announcement of a foodborne
illness outbreak or food recall. In response to the 2006 fresh, bagged
spinach recall which followed a

[[Page 20991]]

multistate outbreak of Escherichia coli O157: H7 infections (Ref. 3),
18 percent of consumers said they stopped buying other bagged, fresh
produce because of the spinach recall (Ref. 1).
Research shows that emotion plays a large role in decisionmaking,
and that individuals may not be conscious of its effects on their
behavior (Ref. 4). For example, when people are angry they are likely
to place blame, take action, and want justice to be served (Ref. 5). If
a particular food recall engenders widespread anger and the anger is
coupled with behavior that is less than desirable from a food safety or
nutritional standpoint, it is possible that anger will be the lens
through which future food recall situations are viewed, thus resulting
in similar undesirable behaviors. Findings from this study will help
FDA understand the emotional response to food recalls. This will help
FDA to design more effective consumer food recall messages during and
after a recall.
FDA conducts research and educational and public information
programs relating to food safety under its broad statutory authority,
set forth in section 903(b)(2) of the Federal Food, Drug, and Cosmetic
Act (the FD&C Act) (21 U.S.C. 393(b)(2)), to protect the public health
by ensuring that foods are ``safe, wholesome, sanitary, and properly
labeled,'' and in section 903(d)(2)(C), to conduct research relating to
foods, drugs, cosmetics, and devices in carrying out the FD&C Act.
FDA plans to survey U.S. consumers using a web-based panel of U.S.
households to collect information on consumers' cognitive and emotional
reaction to food recalls. The survey will query consumers on their
recollection of food recalls within the past 5 years; attitude toward
recalled foods; knowledge about particular food recalls; behavior
during the food recall; and assessment and appraisals of
susceptibility, severity, satisfaction, and self-efficacy.
The data will be collected using an online survey. A pool of 10,000
consumers from a Web-based consumer panel will be screened for
eligibility based on age (18+ years) and familiarity with recent food
recalls. One thousand of eligible consumers will be randomly selected
to participate in the survey. The results of the survey will not be
used to generate population estimates.
The estimated total hour burden of the collection of information is
354 hours (table 1 of this document). To help design and refine the
questionnaire, the Center for Risk Communication Research will conduct
cognitive interviews by screening 25 adult consumers in order to obtain
8 respondents for the cognitive interviews. Each screening is expected
to take 5 minutes (0.083 hours) and each cognitive interview is
expected to take 1 hour. The total for cognitive interview activities
is 10 hours (2 hours + 8 hours). Subsequently, we will conduct pretests
of the study questionnaire before it is administered. We expect that
100 invitations, each taking 2 minutes (0.033 hours), will need to be
sent to adult members of the online consumer panel to have 40 of them
complete a 10 minute (0.167 hours) pretest. The total for the pretest
activities is 10 hours (3 hours + 7 hours). We estimate sending 10,000
survey screeners, each taking 1 minute (0.017 hours), to adult members
of the online consumer panel to have 1,000 of them complete a 10 minute
(0.167 hours) survey. The total for the survey activities is 337 hours
(170 hours + 167 hours).
The burden estimate for this study published in the Federal
Register of June 18, 2010 (75 FR 34745), has increased from 234 hours
to 357 hours. The increase in burden hours represents the addition of
cognitive interviews to the study design and correction of a math
error.
In the Federal Register of June 18, 2010 (75 FR 34745), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. FDA received two letters containing multiple
comments in response to the notice. One letter contained comments
outside the scope of the four collection of information topics on which
the notice solicits comments and, thus, will not be addressed here.
(Comment) One comment suggested that the survey should include
consumers whose pets were sickened or had died because of mycotoxins in
pet food that resulted in the 2004 pet food recall.
(Response) FDA agrees that consumers who were affected by the 2004
pet food recall should be included as survey respondents. These
consumers will be included if they are members of the online consumer
panel from which the survey sample will be drawn and they are randomly
selected from the panel. FDA does not believe that the affected
population should be target-sampled because the study focuses on human
food recalls rather than pet food recalls.
FDA estimates the burden of this collection of information as
follows:

Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Annual
Portion of study Number of frequency per Total annual Hours per Total
respondents response responses response hours
----------------------------------------------------------------------------------------------------------------
Cognitive interview screener.............. 25 1 25 5/60 2
Cognitive interview....................... 8 1 8 1/60 8
Pretest screener.......................... 100 1 100 2/60 3
Pretest................................... 40 1 40 10/60 7
Screener.................................. 10,000 1 10,000 1/60 170
Survey.................................... 1,000 1 1,000 10/60 167
---------------------------------------------------------------------
Total................................ .............. .............. .............. ........... 357
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.

II. References

The following references have been placed on display in the
Division of Dockets Management (see ADDRESSES) and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday.
1. Cuite, C., Condry, S., Nucci, M., and Hallman, W., ``Public
Response to the Contaminated Spinach Recall of 2006,'' Publication
number RR-0107-013. New Brunswick, New Jersey: Rutgers, the State
University of New Jersey, Food Policy Institute, 2007.
2. Hallman, W., Cuite, C., and Hooker, N., ``Consumer Responses to
Food Recalls: 2009 National Survey Report,'' Publication number RR-
0109-018. New Brunswick, New Jersey: Rutgers, the

[[Page 20992]]

State University of New Jersey, Food Policy Institute, 2009.
3. Acheson, D., ``Outbreak of Escherichia coli 0157 Infections
Associated with Fresh Spinach--United States, August-September 2006,''
2007. Available at https://first.fda.gov/cafdas/documents/Acheson_Spinach_Outbreak_2006_FDA_pres.ppt.
4. Han, S., Lerner, J.S., and Keltner, D., ``Feelings and Consumer
Decision Making: The Appraisal-Tendency Framework,'' Journal of
Consumer Psychology, 17(3), 158-168, 2007.
5. Lazurus, R.S., Emotion and Adaptation. New York: Oxford
University Press, 1991.

Dated: April 8, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-8936 Filed 4-13-11; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.